Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
Open Access
- 5 April 2012
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 10 (1) , 33
- https://doi.org/10.1186/1741-7015-10-33
Abstract
We conducted a systematic review of evidence from randomized controlled trials to answer the following research question: What are the relative effects of different classes of antihypertensive drugs in reducing the incidence of cardiovascular disease outcomes for healthy people at risk of cardiovascular disease?Keywords
This publication has 62 references indexed in Scilit:
- Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholdsBMJ, 2011
- Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART StudyEuropean Heart Journal, 2009
- First-line drugs for hypertensionCochrane Database of Systematic Reviews, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Effects of Candesartan Compared With Amlodipine in Hypertensive Patients With High Cardiovascular RisksHypertension, 2008
- RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality studyThe Lancet, 2007
- Should Evidence-Based Proof of Drug Efficacy Be Extrapolated to a “Class of Agents”?Circulation, 2003
- Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)Hypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly HypertensivesHypertension, 1999